Concepedia

Michael Groessl

MG

Statistics

Publications

64

Citations

4.2K

H-Index

37

Active since

2005

Affiliations

University of Vienna(Current)

École Polytechnique Fédérale de Lausanne

University Hospital of Bern

University of Bern

Tofwerk (Switzerland)

Michael Groessl is an author at University of Vienna specializing in chemistry, cancer pharmacology, and analytical chemistry.

Publications per year

2005–2024

64

Publications

64

Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity

Zenita Adhireksan, Gabriela E. Davey, Pablo Campomanes et al. · Nature Communications · 2014 · 296 citations · Full text

Medicine, Oncology, Pharmacology +16

High resolution ion mobility-mass spectrometry for separation and identification of isomeric lipids

Michael Groessl, Stephan Gräf, Richard Knochenmuss · The Analyst · 2015 · 214 citations

Life Sciences, Biochemistry, Chemistry +17

Structure−Activity Relationships for NAMI-A-type Complexes (HL)[<i>trans</i>-RuCl<sub>4</sub>L(<i>S</i>-dmso)ruthenate(III)] (L = Imidazole, Indazole, 1,2,4-Triazole, 4-Amino-1,2,4-triazole, and 1-Methyl-1,2,4-triazole): Aquation, Redox Properties, Protein Binding, and Antiproliferative Activity

Michael Groessl, Erwin Reisner, Christian G. Hartinger et al. · Journal of Medicinal Chemistry · 2007 · 213 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Transferring the Concept of Multinuclearity to Ruthenium Complexes for Improvement of Anticancer Activity

Maria G. Mendoza‐Ferri, Christian G. Hartinger, Marco A. Mendoza et al. · Journal of Medicinal Chemistry · 2009 · 185 citations · Full text

Medicine, Medicinal Chemistry, Oncology +14

A Ruthenium Antimetastasis Agent Forms Specific Histone Protein Adducts in the Nucleosome Core

Bin Wu, Michelle S. Ong, Michael Groessl et al. · Chemistry - A European Journal · 2011 · 173 citations · Full text

Life Sciences, Oncology, Pharmacology +10

1–5 of 64